CAMBRIDGE, Mass.--(BUSINESS WIRE)--Shorla Oncology (‘Shorla’), a U.S.-Ireland pharmaceutical company, today announced it has entered into a licensing agreement and strategic partnership with a ...
In 2001, a Time Magazine cover story touted Novartis’ targeted leukemia treatment Gleevec (imatinib) as a new kind of “ammunition in the war against cancer.” Along with a picture of the Gleevec pills, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced that it has raised $35 million in Series B funding, led by Kurma ...
Our Start-up of the Week is Shorla Pharma, which is developing treatments for children’s and women’s cancers to make them more accessible. In 2018, Sharon Cunningham and Orlaith Ryan started Shorla ...
Shorla Oncology® Announces U.S. FDA Approval of Larger Vial Size for Nelarabine Intravenous Administration for the Treatment of T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma ...
The Ireland and US-based pharma company has been advancing its oncology drugs for orphan and paediatric cancers since it was founded in 2018. Shorla Oncology, a pharmaceutical company based in Ireland ...
When Opko Health bought Ireland’s EirGen in 2015, colleagues Sharon Cunningham and Orlaith Ryan wasted no time. Zeroing in on gaps in cancer care, the duo started building its own oncology company, ...
Shorla Oncology co-founders Orlaith Ryan (left) and Sharon Cunningham. Seven months after netting its first FDA approval, a biotech startup with roots in Ireland is putting $35 million toward growing ...
Validation is a word that pops up naturally in conversation with Sharon Cunningham and Orlaith Ryan, co-founders of Shorla Oncology and reigning EY Entrepreneurs of the Year. The much-prized award – ...
The developer is a United Kingdom-based drug development and manufacturing company, providing integrated R&D and manufacturing capabilities to accelerate entry of PIP-101 in the U.S. market Shorla ...
CAMBRIDGE, Mass., January 28, 2026--(BUSINESS WIRE)--Shorla Oncology ('Shorla'), a U.S.-Ireland specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results